Prostatype Genomics AB (OSTO:PROGEN) Interest Expense : kr-0.41 Mil (TTM As of Jun. 2023)

View and export this data going back to 2020. Start your Free Trial

What is Prostatype Genomics AB Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Prostatype Genomics AB's interest expense for the three months ended in Jun. 2023 was kr -0.03 Mil. Its interest expense for the trailing twelve months (TTM) ended in Jun. 2023 was kr-0.41 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Prostatype Genomics AB's Operating Income for the three months ended in Jun. 2023 was kr -10.06 Mil. Prostatype Genomics AB's Interest Expense for the three months ended in Jun. 2023 was kr -0.03 Mil. Prostatype Genomics AB did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Prostatype Genomics AB Interest Expense Historical Data

The historical data trend for Prostatype Genomics AB's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Prostatype Genomics AB Interest Expense Chart

Prostatype Genomics AB Annual Data

Trend

Jun18

Jun19

Dec21

Dec22

Dec23

Interest Expense

-0.16

-0.68

-0.08

-0.40

-1.54

Prostatype Genomics AB Quarterly Data
	Jun18	Jun19	Mar20	Jun20	Sep20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Dec23
Interest Expense	Get a 7-Day Free Trial											-0.34	-0.02	-0.02	-0.03	-

Prostatype Genomics AB Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Jun. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-0.41 Mil.

Prostatype Genomics AB (OSTO:PROGEN) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Prostatype Genomics AB's Interest Expense for the three months ended in Jun. 2023 was kr-0.03 Mil. Its Operating Income for the three months ended in Jun. 2023 was kr-10.06 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Jun. 2023 was kr0.27 Mil.

Prostatype Genomics AB's Interest Coverage for the quarter that ended in Jun. 2023 is calculated as

Prostatype Genomics AB did not have earnings to cover the interest expense.

The higher the ratio, the stronger the company's financial strength is.

Prostatype Genomics AB (OSTO:PROGEN) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Prostatype Genomics AB (OSTO:PROGEN) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

PGO:Germany

Address

Gustaf III:s Boulevard 34, Solna, SWE, 169 73

Website

https://www.prostatypegenomics.com

Prostatype Genomics AB manufactures, markets and sells the prognostic gene test Prostatype. By assessing the aggressiveness of prostate cancer, Prostatype helps clinicians and patients to make correct treatment decisions. Over and under treatment of prostate cancer can be minimized, the quality of life for the patient improved and money can be saved for the health care sector.

Prostatype Genomics AB (OSTO:PROGEN) Headlines

No Headlines